IRBM Reports Breakthrough in Zika Virus Drug Discovery
ROME, Feb. 10, 2026 /PRNewswire/ -- IRBM, a leader in early drug discovery research, has announced a major scientific breakthrough with the discovery of a novel and potent allosteric inhibitor targeting the Zika virus (ZIKV) protease (NS2B-NS3). The...
Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology
SAN FRANCISCO and SUZHOU, China, Feb. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
Global Mind Australia and Farmacist enter strategic partnership to advance precision, sustainable agriculture from Australia to ASEAN
BRISBANE, Australia, Feb. 5, 2026 /PRNewswire/ -- through Global Mind Australia (GMAA), AgriS (Thanh Thanh Cong – Bien Hoa Joint Stock Company, HOSE: SBT) and Farmacist, the largest independent agronomic service provider and advisory firm in the...
SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech
- SanegeneBio grants exclusive worldwide license to one of its RNAi programs to Genentech - SanegeneBio to receive $200 million upfront payment and will be eligible to receive development and commercialization milestone payments, totaling up to $1.5...
MIFF 2026 AND MATRADE PARTNERSHIP TO FURTHER ENHANCE GLOBAL STATUS OF HIGH-QUALITY MALAYSIAN FURNITURE
Collaboration to positively impact industry on a local and international scale KUALA LUMPUR, Malaysia, Jan. 30, 2026 /PRNewswire/ -- The Malaysian International Furniture Fair (MIFF) 2026 today entered into an Exchange of Cooperation Document with...
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease
Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. License and collaboration agreement strengthen Boehringer's inflammatory disease pipeline with a...
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
CEPI to provide up to USD 30 million to support development of MSD's Zaire ebolavirus vaccine Collaboration addresses manufacturing complexity and cold-chain challenges to improve yield and thermostability Partnership aims to expand affordable and...
AheadComputing Inc. Raises Additional $30M Seed2 Round to Reimagine CPU Architecture
The company will use the follow-on seed to advance the development of its high-performance CPU microarchitecture designed for the surging compute demands of AI workloads PORTLAND, Ore., Jan. 22, 2026 /PRNewswire/ -- AheadComputing, Inc., the company...
Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for Precision Screening and Cancer Care in the U.S.
IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader in validation platforms for Laboratory Developed Tests...
Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases treatment
Insilico Medicine and Hygtia Therapeutics, an incubatee of Shenzhen Pengfu Fund of Fosun Health Capital and Fosun Pharma, have entered into an exclusive license and co-development collaboration to advance ISM8969 worldwide. Under the agreement, both...